Improved outcomes with home-based administration of palivizumab: Results from the 2000-2004 palivizumab outcomes registry

Pediatric Infectious Disease Journal

Volumn 27, Issue 10, 2008, Pages 870-873

  Frogel, Michael ^a   Nerwen, Cliff ^a   Boron, Marnie ^b   Cohen, Alan ^b   Vanveldhuisen, Paul ^c   Harrington, Molly ^c   Groothuis, Jessie ^b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b MEDIMMUNE   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

Bronchiolitis; Home delivery; Hospitalization; Prematurity

Indexed keywords

PALIVIZUMAB; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY;

ARTICLE; BRONCHIOLITIS; CHILD HOSPITALIZATION; HOME CARE; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PREMATURITY; PRIORITY JOURNAL; REGISTER; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; MALE; NEWBORN; PRESCHOOL CHILD; STATISTICS; VIRAL BRONCHIOLITIS; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PATIENT COMPLIANCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 54049150062     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318174e0c4     Document Type: Article

References (15)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282:1440-1446.
2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127-S132.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
4. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr. 2000;137:865-870.
5. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982;307:397-400.
6. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992;121:348-354.
7. Frogel M, Nerwen C, Cohen A, Van Veldhuisen P, Harrington M, Boron M, for the Palivizumab Outcomes Registry Group. Prevention of hospital-ization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry. J. Perinatal. 2008;28:511-517.
8. Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J. 2003;22(2 Suppl):S46-S54.
9. Hayes C, Wilkerson S, Bibb K, Schuschke L, Guest A. Effectiveness of RSV-IVIG in premature infants: success in the home. Pediatrics. 1999; 103:698-699.
10. Weber M, Reno S, Hornbake R, Shillington A. An in-home Synagis program for RSV prevention in high-risk infants. J Managed Care Pharm. 2001;7:476-481.
11. Hand IL, Noble L, Geiss D, Shotkin A. Respiratory syncytial virus immunoprophylaxis in an urban population: a comparison of delivery strategies and outcomes. Pediatr Infect Dis J. 2008;27:175-176.
12. Golombek SG, Berning F, Lagamma EF. Compliance with prophylaxis for respiratory syncytial virus infection in a home setting. Pediatr Infect Dis J. 2004;23:318-322.
13. Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22:857-862.
14. Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M. Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiolog-ical study. BMC Infect Dis. 2005;5:20.
15. Goldenring J. Give Synagis via Home health. Pediatrics. 2007;119:219.